[Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].

Brogard JM, Neyrolles N, Andres E, Blicklé JF

Open source

DOI
10.1016/s0248-8663(99)80510-4
Published
1999 Aug
Container
La Revue de medecine interne
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0248-8663-99-80510-4,
  title = {[Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].},
  author = {Brogard JM and Neyrolles N and Andres E and Blicklé JF},
  year = {1999},
  journal = {La Revue de medecine interne},
  doi = {10.1016/s0248-8663(99)80510-4},
  url = {https://doi.org/10.1016/s0248-8663(99)80510-4}
}

RIS

TY  - JOUR
TI  - [Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].
AU  - Brogard JM
AU  - Neyrolles N
AU  - Andres E
AU  - Blicklé JF
PY  - 1999
JO  - La Revue de medecine interne
DO  - 10.1016/s0248-8663(99)80510-4
UR  - https://doi.org/10.1016/s0248-8663(99)80510-4
ER  - 

APA

JM, B., N, N., E, A., & JF, B. (1999). [Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].. La Revue de medecine interne. https://doi.org/10.1016/s0248-8663(99)80510-4

Source records